Form 8-K - Current report:
SEC Accession No. 0000950170-25-066933
Filing Date
2025-05-08
Accepted
2025-05-08 16:08:09
Documents
16
Period of Report
2025-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sana-20250508.htm   iXBRL 8-K 67426
2 EX-1.1 sana-ex1_1.htm EX-1.1 374921
3 EX-5.1 sana-ex5_1.htm EX-5.1 20227
4 EX-99.1 sana-ex99_1.htm EX-99.1 227802
5 GRAPHIC img155791035_0.jpg GRAPHIC 321697
6 GRAPHIC img155791035_1.jpg GRAPHIC 37721
  Complete submission text file 0000950170-25-066933.txt   1395185

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sana-20250508.xsd EX-101.SCH 31887
18 EXTRACTED XBRL INSTANCE DOCUMENT sana-20250508_htm.xml XML 4892
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39941 | Film No.: 25926040
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)